Celgene to invest $1 billion in Juno to partner in cancer therapies

Fox BusinessCelgene to invest $1 billion in Juno to partner in cancer therapiesReutersCelgene Corp said it would invest about $1 billion in Juno Therapeutics Inc to partner in the development and marketing of immunotherapies for the treatment of cancer and autoimmune diseases. Juno's shares were up about 33 percent in heavy extended ...Juno Rises as Celgene Pays $1 Billion to Buy Cancer StakeBloombergJuno stock skyrockets after Celgene invests $1 billion to change the way ...GeekWireCompaniesJuno shares leap as rival backs cancer treatmentFinancial Timesall 34 news articles »

Share this post